Target intelligence / Profile preview

Flavin mononucleotide riboswitch (FMN riboswitch)

Target
FMN riboswitch
Molecular classification
Riboswitch, Non-coding RNA, Regulatory RNA, Cis-regulatory element
01

Overview

The Flavin mononucleotide (FMN) riboswitch, also known as the RFN element, is a highly conserved regulatory RNA element found in the 5' untranslated regions of bacterial messenger RNAs (Winkler et al., 2002). It functions as a metabolite-sensing genetic switch that binds FMN with high affinity and specificity to regulate the expression of genes involved in the biosynthesis and transport of riboflavin (Serganov et al., 2009). Upon binding FMN, the riboswitch undergoes a conformational change that typically leads to the formation of a rho-independent transcription terminator or the sequestration of the ribosome-binding site, effectively shutting down gene expression (Howe et al., 2015). Because riboswitches are prevalent in bacteria but absent in humans, they represent promising targets for the development of novel classes of antibiotics (Blount & Breaker, 2006). Small molecules like the natural antibiotic Roseoflavin and the synthetic compound Ribocil have been shown to target the FMN riboswitch, inhibiting bacterial growth by mimicking the natural ligand and suppressing essential metabolic pathways (Howe et al., 2015; Ott et al., 2009). This mechanism of action provides a pathway for treating infections caused by pathogens that rely on endogenous riboflavin production.

Other names
RFN elementRiboflavin riboswitchFMN-sensing riboswitch
02

Mechanism of action

The drug binds to the aptamer domain of the riboswitch, inducing a conformational change in the expression platform that results in premature transcription termination or inhibition of translation initiation, thereby downregulating genes required for riboflavin biosynthesis (Howe et al., 2015).

03

Biological functions

Gene expression regulationRiboflavin metabolic processTranscription attenuationTranslation regulation
04

Disease associations

Bacterial infection
05

Safety considerations

Spontaneous mutations in the aptamer domain leading to rapid drug resistance (Howe et al., 2015)Potential for off-target binding to other highly structured bacterial RNAsLimited efficacy against bacteria with robust riboflavin salvage pathways
06

Interacting drugs

Roseoflavin

2 more in the full profile.

07

Biomarkers

Intracellular riboflavin levelsExpression levels of rib genesBacterial growth inhibition

Beyond the preview

Go deeper on Flavin mononucleotide riboswitch (FMN riboswitch).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flavin mononucleotide riboswitch (FMN riboswitch).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call